Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Invesco Biotechnology & Genome ETF PBE

Full chart Compare
Set alert

Price alert · PBE

All alert types
99.20 USD -5.47 (-5.23%)

At closeNov 5, 2026, 4:49 PM EST

98.72 -0.48 -0.48%

After hours · Nov 5, 4:49 PM ET

99.11 Day range 103.10
75.10 52-week range 104.69
YTD
+20.75%
1 year
+29.23%

Invesco Biotechnology & Genome ETF

Issuer
Invesco
Asset class
Equity
Expense ratio
0.59%
Assets under management
$452.40M
NAV
104.72
Holdings
31
Inception
2005-06-23
Top 10 weight
48.77%

Top holdings

  1. GILD Gilead Sciences Inc 5.52%
  2. NTRA Natera Inc 5.47%
  3. BIIB Biogen Inc 5.43%
  4. REGN Regeneron Pharmaceuticals Inc 5.26%
  5. RPRX Royalty Pharma PLC 5.12%
  6. AMGN Amgen Inc 5.09%
  7. ILMN Illumina Inc 4.74%
  8. VRTX Vertex Pharmaceuticals Inc 4.67%
  9. MRNA Moderna Inc 4.18%
  10. EXEL Exelixis Inc 3.29%
  11. VCYT Veracyte Inc 3.06%
  12. HALO Halozyme Therapeutics Inc 3.06%
  13. UTHR United Therapeutics Corp 3.01%
  14. QGEN QIAGEN NV 2.99%
  15. NVAX Novavax Inc 2.90%
  16. TGTX TG Therapeutics Inc 2.86%
  17. NBIX Neurocrine Biosciences Inc 2.78%
  18. LEGN Legend Biotech Corp 2.74%
  19. VCEL Vericel Corp 2.70%
  20. SRPT Sarepta Therapeutics Inc 2.58%
  21. RGEN Repligen Corp 2.52%
  22. PTGX Protagonist Therapeutics Inc 2.44%
  23. INCY Incyte Corp 2.43%
  24. PTCT PTC Therapeutics Inc 2.41%
  25. ARDX Ardelyx Inc 2.23%

Sector weights

  • Healthcare 99.96%
  • Financial Services 0.04%
  • Cash & Others 0.00%

Country weights

  • United States 100.00%

Updated 2026-11-05

Held by funds

2 US ETFs and mutual funds hold PBE · largest positions

Funds holding PBE, by value held
FundValue heldWeight in fund
DALT $1.50M2.90%
TIH $251.21K0.04%